ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç° ¹× ¼­ºñ½ºº°, ¿öÅ©Ç÷ο캰, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÎ¹® ¿¹Ãø(2025-2030³â)
Whole Genome Bisulfite Sequencing Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents), By Workflow, By Application (Drug Development, Stem Cell Research), By End-use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1678705
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 100 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 7¾ï 4,940¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2030³â±îÁö CAGR 16.8%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

ÀÌ ½ÃÀåÀº ÈļºÀ¯Àü°ú DNA ¸Þƿȭ ¿¬±¸ Áõ°¡·Î »ó´çÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÈļºÀ¯ÀüÀÚ º¯Çü, ƯÈ÷ DNA ¸Þƿȭ´Â À¯ÀüÀÚ Á¶Àý, ¾Ï ÁøÇà, ½Å°æÁúȯ, ¹ß»ý »ý¹°Çп¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯ÇüÀ» ÇØµ¶Çϱâ À§ÇÑ Ã·´Ü ½ÃÄö½Ì ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½ÌÀÇ Ã¤ÅÃÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °úÇÐÀÚµéÀÌ ¸Þƿȭ ÆÐÅϰú Áúº´ »óÅÂÀÇ ¿¬°ü¼ºÀ» ÀÌÇØÇÏ·Á°í ³ë·ÂÇÏ´Â µ¿¾È, ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½ÌÀº À¯Àüü ÀüüÀÇ ¸Þƿȭ ºÐ¼®ÀÇ ÃÖÀûÇ¥ÁØÀ¸·Î µîÀåÇÏ¿© ´ÜÀÏ ¿°±â ÇØ»óµµ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ¶§¹®¿¡ ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö, Á¤¹ÐÀÇ·á, ÀǾàǰ °³¹ß¿¡ÀÇ ÀÀ¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

Á¤ºÎ±â°ü°ú ¹Î°£ÅõÀÚÀÚÀÇ ÀÚ±ÝÁ¶´Þ Áõ°¡´Â ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ±â¼úÀÇ È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ Áúº´°ú °ü·ÃµÈ ÈļºÀ¯Àü¼º ¸¶Ä¿¸¦ Á¶»çÇϱâ À§ÇØ ±¹³» ¹× ±¹Á¦ ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê°¡ ¸¹ÀÌ Ãâ½ÃµÇ¾î ½ÃÀå ¼ºÀåÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù. Á¦¾à±â¾÷°ú ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷Àº ½ÃÄö½Ì ±â¼ú¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½ÌÀ» Ȱ¿ëÇÏ¿© Ç¥Àû Ä¡·á ¹× ¸ÂÃãÇü Ä¡·á °èȹÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. Á¤¹ÐÀÇ·á°¡ Á߽õǰí ÀÖ´Â °¡¿îµ¥, ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½ÌÀº °³ÀÎ °£ÀÇ À¯ÀüÀû ¹× ÈļºÀû º¯À̸¦ ÀÌÇØÇÏ´Â µ¥ ÇʼöÀûÀÎ µµ±¸°¡ µÇ°í ÀÖÀ¸¸ç, º¸´Ù È¿°úÀûÀÎ ÀǾàǰ °³¹ß°ú Áúº´ °ü¸®¸¦ °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.

ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀåÀÇ È®´ë¿¡ À־ ±â¼úÀÇ Áøº¸µµ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. °í󸮷® ½ÃÄö½Ì Ç÷§Æû, Çâ»óµÈ Áß ¹ÙÀ̼³ÆÄÀÌÆ® º¯È¯ ¹æ¹ý, È¿¼Ò ±â¹Ý ´ëü ¹æ¹ýÀÇ °³¹ß·Î µ¥ÀÌÅÍÀÇ Á¤È®¼º, È¿À²¼º ¹× Àü¹ÝÀûÀÎ ½ÃÄö½Ì Ãâ·ÂÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. º¸´Ù ºñ¿ë È¿À²ÀûÀÎ ÇÕ¸®ÀûÀÎ ¿öÅ©Ç÷οìÀÇ µµÀÔÀ¸·Î ¿¬±¸Àڵ鿡°Ô ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½ÌÀÌ ´õ¿í ¿ëÀÌÇØÁ³°í, ÀÌÀü¿¡´Â ±× µµÀÔÀ» Á¦ÇÑÇß´ø °æÁ¦Àû À庮ÀÌ ÁÙ¾îµé¾ú½À´Ï´Ù. °¢ ȸ»ç´Â ±âÁ¸ÀÇ ¹ÙÀ̼³ÆÄÀÌÆ® º¯È¯¹ý°ú °ü·ÃµÈ DNA ¼Õ»ó ¹× ¹ÙÀ̾¸¦ ÃÖ¼ÒÈ­ÇÏ°í º¸´Ù ºü¸£°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ½ÃÄö½Ì ¼Ö·ç¼ÇÀ» °³¹ßÇϱâ À§ÇØ ²÷ÀÓ¾ø´Â ±â¼ú Çõ½ÅÀ» ½Ç½ÃÇß½À´Ï´Ù. ÀÚµ¿È­ ¹× Ŭ¶ó¿ìµå ±â¹Ý ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ¼Ö·ç¼ÇÀÇ °¡¿ë¼ºÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½ÌÀÇ º¸±ÞÀÌ ´õ¿í ÃËÁøµÇ¾î ¿¬±¸ÀÚµéÀº ´ë±Ô¸ð µ¥ÀÌÅÍ ¼¼Æ®¸¦ º¸´Ù ³ôÀº È¿À²°ú Á¤È®µµ·Î ó¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

Á¾¾çÇÐ, Áٱ⼼Æ÷ ¿¬±¸, ½Å°æ°úÇÐ, ¹ß»ý »ý¹°ÇÐ µî ´Ù¾çÇÑ ¿¬±¸ ºÎ¹®¿¡¼­ ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½ÌÀÇ ÀÀ¿ëÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¾Ï ¿¬±¸´Â ¸ÞƿȭÀÇ º¯È­°¡ Á¾¾ç Çü¼ºÀÇ Áß¿äÇÑ ÁöÇ¥·Î¼­ ³Î¸® Àνĵǰí Àֱ⠶§¹®¿¡ Å« ÃßÁø·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. À¯Àüü ÀüüÀÇ ¸Þƿȭ ÆÐÅÏÀ» ¸ÅÇÎÇÔÀ¸·Î½á ¿¬±¸ÀÚ´Â ¾ÏÀÇ Á¶±â ¹ß°ß, ¿¹ÈÄ, Ä¡·á Ç¥Àû¿¡ ´ëÇÑ ÀáÀçÀûÀÎ ¹ÙÀÌ¿À¸¶Ä¿¸¦ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. À¯»çÇϰÔ, ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½ÌÀº Áٱ⠼¼Æ÷ ¿¬±¸¿¡¼­ ¼¼Æ÷ ºÐÈ­ ¹× ÀçÇÁ·Î±×·¡¹ÖÀ» ¿¬±¸Çϱâ À§ÇØ ³Î¸® »ç¿ëµÇ¸ç, Àç»ý ÀÇ·á¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÀÌ ±â¼úÀº ½Å°æ°úÇÐ ºÎ¹®¿¡¼­µµ ÁÖ¸ñÀ» ¹Þ°í ÀÖÀ¸¸ç ¾ËÃ÷ÇÏÀ̸Ӻ´°ú ÆÄŲ½¼º´°ú °°Àº ½Å°æÅðÇ༺ Áúȯ°ú °ü·ÃµÈ ÈļºÀû º¯È­¸¦ Á¶»çÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù.

°­·ÂÇÑ ¼ºÀå ±Ëµµ¿¡µµ ºÒ±¸Çϰí, ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀåÀº È®ÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ´Â ¸î °¡Áö °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¾ïÁ¦¿äÀÎ Áß Çϳª´Â ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì°ú °ü·ÃµÈ ³ôÀº ºñ¿ëÀÔ´Ï´Ù. º¹ÀâÇÑ ¿öÅ©Ç÷οì, °í°¡ÀÇ ½Ã¾à, °í¼º´É ÄÄÇ»ÆÃ ÀÎÇÁ¶ó ¿ä±¸ »çÇ×Àº Àü¹ÝÀûÀÎ ºñ¿ë ºÎ´ãÀÇ ¿øÀÎÀÌ µÇ¸ç, ¿¹»êÀÌ Á¦ÇÑµÈ ¼Ò±Ô¸ð ½ÇÇè½Ç ¹× ¿¬±¸ ±â°ü¿¡ »ç¿ëÇϱ⠾î·Á¿öÁö°í ÀÖ½À´Ï´Ù.

ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀå : Á¦Ç° ¹× ¼­ºñ½ºº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦5Àå ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀå : ¿öÅ©Ç÷ο캰, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦6Àå ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀå : ¿ëµµº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦7Àå ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦8Àå ÀüÀå À¯Àüü ¹ÙÀ̼³ÆÄÀÌÆ® ½ÃÄö½Ì ½ÃÀå : Áö¿ªº°, ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦9Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Whole Genome Bisulfite Sequencing Market Growth & Trends:

The global whole genome bisulfite sequencing market size is anticipated to reach USD 749.4 million by 2030 and is expected to grow at a CAGR of 16.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing substantial growth, driven by increasing research in epigenetics and DNA methylation studies. Epigenetic modifications, particularly DNA methylation, play a critical role in gene regulation, cancer progression, neurological disorders, and developmental biology. The demand for advanced sequencing technologies to decode these modifications is propelling the adoption of whole genome bisulfite sequencing. As scientists strive to understand the link between methylation patterns and disease states, whole genome bisulfite sequencing has emerged as the gold standard for genome-wide methylation analysis, offering single-nucleotide resolution. This has led to its growing application in biomarker discovery, precision medicine, and drug development.

The rise in funding from both government agencies and private investors has significantly contributed to the expansion of whole genome bisulfite sequencing technologies. Numerous national and international research initiatives are being launched to investigate epigenetic markers associated with various diseases, further fueling market growth. Pharmaceutical and biotechnology companies are investing heavily in sequencing technologies, leveraging whole genome bisulfite sequencing to develop targeted therapies and personalized treatment plans. With the growing emphasis on precision medicine, whole genome bisulfite sequencing is becoming an essential tool for understanding genetic and epigenetic variations among individuals, allowing for more effective drug development and disease management.

Technological advancements have also played a crucial role in the expansion of the whole genome bisulfite sequencing market. The development of high-throughput sequencing platforms, improved bisulfite conversion methods, and enzyme-based alternatives have enhanced data accuracy, efficiency, and overall sequencing output. The introduction of more cost-effective and streamlined workflows has made whole genome bisulfite sequencing more accessible to researchers, reducing the financial barriers that previously limited its adoption. Companies are constantly innovating to create faster, more reliable sequencing solutions, minimizing DNA damage and bias associated with traditional bisulfite conversion methods. The increasing availability of automation and cloud-based bioinformatics solutions has further facilitated the widespread adoption of whole genome bisulfite sequencing, enabling researchers to process large datasets with greater efficiency and accuracy.

The growing applications of whole genome bisulfite sequencing across various research fields, including oncology, stem cell research, neuroscience, and developmental biology, have also contributed to its market expansion. Cancer research, in particular, has been a significant driver, as methylation changes are widely recognized as key indicators of tumorigenesis. By mapping methylation patterns across the genome, researchers can identify potential biomarkers for early cancer detection, prognosis, and therapeutic targeting. Similarly, whole genome bisulfite sequencing is being extensively used in stem cell research to study cellular differentiation and reprogramming, offering valuable insights into regenerative medicine. The technique is also gaining traction in neuroscience, where it is used to explore epigenetic changes associated with neurodegenerative disorders such as Alzheimer's and Parkinson's disease.

Despite the strong growth trajectory, the whole genome bisulfite sequencing market faces several challenges that may hinder its expansion. One of the primary restraints is the high cost associated with whole genome bisulfite sequencing. The complex workflow, expensive reagents, and requirement for high-performance computing infrastructure contribute to the overall cost burden, making it less accessible to smaller research laboratories and institutions with limited budgets.

Whole Genome Bisulfite Sequencing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Whole Genome Bisulfite Sequencing Market Variables, Trends, & Scope

Chapter 4. Whole Genome Bisulfite Sequencing Market: Product & Service Estimates & Trend Analysis

Chapter 5. Whole Genome Bisulfite Sequencing Market: Workflow Estimates & Trend Analysis

Chapter 6. Whole Genome Bisulfite Sequencing Market: Application Estimates & Trend Analysis

Chapter 7. Whole Genome Bisulfite Sequencing Market: End Use Estimates & Trend Analysis

Chapter 8. Whole Genome Bisulfite Sequencing Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â